Leading from strategy to execution with the patient in mind.

20 years’ industry and consulting experience

 

With an international experience of 20 years in the industry at corporate level, with companies such as Novartis, Novo Nordisk, Wyeth/Pfizer, Vifor, Vifor-Fresenius, GC Aesthetics, Bachem and other global clients. MSH-Consulting ensures excellence of service.

Get in touch

Broad pharmaceutical experience

Work experience for international companies at corporate level, e.g. Novartis, Novo Nordisk, Wyeth/Pfizer, Vifor, Vifor-Fresenius, GC Aesthetics, Bachem and global clients on consultancy basis.

Numerous indications

Cardio-Renal, Diabetes, Gynaecology, Immunology, Infectious Disease, Nephrology, Oncology, Transplantation, Aesthetic Surgery, Medicinal Products, and more.

 

From Strategy to Execution

Your success is ensured with our business-focused strategies

MSH Solutions

​MSH Solutions, founded by Dr. Manuela Schneider in 2018, is a healthcare marketing consultancy. It is focusing on strategy and brand performance to help companies reaching goals efficiently and in time.

Business focus

  • Developing strategies

  • Delivering launch success

  • Optimising brand performance

  • Leading consultancy projects and teams ad interim

Goals

  • Best results by advising and providing expert consultancy

  • Meet timelines due to disciplined delivery of complex projects

  • Inspire teams by coaching, aligning communication and clear responsibilies

Solution oriented from strategic planning to execution.

Inspired by strong work relationships, challenging business tasks, transformational processes, pragmatic solutions built on solid analytics, sustainable results and people and cultural diversity.

Experience & skills

  • Over 20 years’ industry experience in marketing and commercial

  • PhD in biochemistry and master in immunology and molecular biology

  • Translating complex science into winning commercial strategies

  • Organized planner and strong executer

  • Entrepreneurial, decisive and innovative team leadership

Living the vision

  • Build reliable
  • Trustful relationships with customers
  • Team up to optimise strategy
  • Business performance and ease patients’ lives

Get your products on the path to success

Develop strategies

  • Develop commercial and go-to market strategies for organisations and products

  • Evaluate commercial potentials by establishing forecasts, investments, NPVs and business development opportunities

  • Contribute to market access and pricing strategies

3. Optimize brand performance

  • Establish strategic plans for brands and portfolio

  • Translate strategy into operational plans

  • Identify KPIs and smart objectives

  • Set-up marketing excellence programs

  • Develop customer facing and training material

Deliver launch success

  • From preparation of pre-launch plans to winning launch plans

  • Establish cross-functional plans to align teams

Lead consultancy projects

  • Interim team leadership on functional and cross-functional level

  • Agency management

  • Budget and time management

Scientific publications and presentations

Recent Interviews

Mutmacher” Buch – Portraits of people in industry taking courageous decisions and encouraging others. 2018 by Süddeutsche Newspaper.
https://www.wir-sind-mutmacher.com

Presentations

Navigating the Digital World, Digital Femal Leaders 2017, 4th Annual Summit, Berlin 2017

Horizontal vs vertical extension in healthcare: Innovative business concepts beyond the pill, Global Pharma Marketing Leaders, Annual Summit, Berlin, 2015

Development of a digital medical education platform to increase disease awareness, 6th Digital Pharma Europe, Bayer Pharma, Berlin, 2015

A global perspective on market access – hurdles and opportunities, 3rd Annual Pharma Commercial and SFE, Berlin, 2013

To get the price right – a key element in today’s launch preparation, Eyeforpharma, Barcelona, 2013

Scientific background

M. Schneider-Höfferer. (1999), Regulation of E2F1 in Response to DNA Damage (Part I), Cloning and Characterization of Two Novel F-Box Proteins. Dissertation

M.Höfferer, C. Wirbelauer, B. Humar, W. Krek. (1999), Increased Levels of E2F-1 Dependent DNA Binding Activity After UV or Gamma-Irradiation: Evidence for a Role of E2F-1 in the DNA Damage Response Pathway. Nucleic Acid Research 27, p 491-495

H.-P. Gerber, K. Seipel, O. Georgiev, M. Höfferer, M. Hug, S. Rusconi, W. Schaffner. (1994), Transcriptional Activation Modulated by Homopolymeric Glutamine and Proline Stretches. Science 263, p 808-811

M.Höfferer. (1994) Distinct Effects of Homopolymeric Amino-Acid Repeats on the Activity of Natural and Chimeric Transcription Factors. Diploma Work